T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. (2021)
Attributed to:
MICA: ERADICATE HIV-1: TARGETING THE HIV-1 RESERVOIR WITH NEW IMMUNOTHERAPEUTIC STRATEGIES
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41591-020-01194-5
PubMed Identifier: 33335323
Publication URI: http://europepmc.org/abstract/MED/33335323
Type: Journal Article/Review
Volume: 27
Parent Publication: Nature medicine
Issue: 2
ISSN: 1078-8956